Healthcare

April 24, 2014

1

The American Health Information Management Association (AHIMA) to partner on the Middle East Healthcare Informatics Summit in Dubai

The Middle East has been witnessing a boom in healthcare investments and this will continue to grow in the years to come. According to a report of Frost & Sullivan, healthcare spend in the region in 2011 was estimated to be USD 46.12 billion and is estimated to reach USD 133.19 billion by 2018.


Middle East Healthcare Informatics Summit (MEHIS) 2014 will engage local"...

Continue Reading >

April 24, 2014

2

Quintiles and Biogen Idec Announce Comprehensive Clinical Development Partnership

Quintiles, the world’s largest provider of biopharmaceutical development and commercial outsourcing services, and Biogen Idec (NASDAQ: BIIB) have entered into a five-year strategic clinical development agreement. The multi-year collaboration is designed to leverage the expertise and experience from both organizations to optimize Biogen Idec’s clinical development processes.


The"...

Continue Reading >

April 23, 2014

3

Aetna Completes Acquisition of Interglobal Group

Aetna (NYSE: AET) today announced that it has completed its acquisition of United Kingdom-based InterGlobal from a group led by its majority shareholder Alchemy Partners. InterGlobal specializes in international private medical insurance for groups and individuals in the Middle East, Asia, Africa and Europe.



About Aetna


Aetna"......

Continue Reading >

April 22, 2014

4

Shiseido Opens Research Facility Dedicated to Hair Regeneration

Shiseido Co., Ltd. (TOKYO:4911) announces plans to open the Shiseido Cell-Processing and Expansion Center (SPEC) on May 1, 2014. The center, located in the in the Kobe Biomedical Innovation Cluster in Kobe, Japan, will centralize research and development on hair regenerative medicine with an aim toward commercialization.


Regenerative medicine in Japan is an emerging industry which the government aims to foster through new legislation"......

Continue Reading >

April 21, 2014

5

Zayed Future Energy Prize Winner Partners with Finalist to Implement Winning Project

Kalkeri Sangeet Vidyalaya (KSV), the 2014 Zayed Future Energy Prize winner in the Global High School category for Asia, has partnered with 2014 SME finalist, SELCO India to implement its award-winning sustainability project.


The winners and finalists of the Prize were recognised during the 2014 Zayed Future Energy Prize award ceremony that took place on January 20, as part"...

Continue Reading >

April 17, 2014

6

Volasertib, Boehringer Ingelheim´s investigational treatment of acute myeloid leukaemia, is granted ‘orphan drug designation’ in the EU and the US

  • An orphan drug is a medicine that treats a rare disease
  • Although a rare disease, acute myeloid leukaemia is one of the most common adult leukaemias1
  • EMA & FDA recognise volasertib’s promise as a potential new treatment for patients with acute myeloid leukaemia who are not eligible for intensive treatment
  • Currently %40% of AML patients are unlikely to benefit from intensive therapy options2


For"...

Continue Reading >

April 17, 2014

7

Quintiles Recognized as Industry Leader in Phase II/III Research for Second Year in a Row

(ME NewsWire)-- For the second year in a row, Quintiles has been named the industry leader that best differentiates itself on service quality for Phase II/III research in Industry Standard Research’s (ISR) 2014 CRO"......

Continue Reading >

April 17, 2014

8

Leading Business Speaker confirmed for Middle East Forum on Quality and Safety in Healthcare

Dan Heath, leading author and Senior Fellow from the Duke University CASE School of Business in the USA, has been confirmed as the keynote speaker at the forthcoming 2014 Middle East Forum for Quality and Safety in Healthcare, scheduled to be held here from 25 to 27 April.


Mr Heath, co-author of Switch: How to Change Things When Change Is Hard, which debuted at number 1"...

Continue Reading >

April 16, 2014

9

ASCO, ESMO, EORTC, ESO, and UICC Continue Endorsing the WIN Symposium Series in 2014

WIN 2014 Symposium

Five major cancer organizations which have endorsed previous events in the WIN Symposium Series, are also endorsing the WIN 2014 Symposium, to be held in Paris, June 23 - 24. The high scientific level and expected strong impact of this symposium are reflected by endorsements received from ASCO*, ESMO, EORTC, ESO, and UICC.

...

Continue Reading >

April 13, 2014

10

Real-World Patient Survey Data Shows Negative Impact of Nocturia

New patient survey data presented today at the European Association of Urology (EAU 14) congress, showed that nocturia (waking to void one or more times a night followed by sleep), has a strong negative impact on utility, work productivity and health-related quality of life (HRQL), which increases with the severity of the condition1,2.


An analysis of survey data drawn from"...

Continue Reading >